{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:12:44Z","timestamp":1773418364009,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3627,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1038\/sj.ki.5000091","type":"journal-article","created":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T12:00:39Z","timestamp":1137067239000},"page":"218-223","source":"Crossref","is-referenced-by-count":51,"title":["New insights into mineral and skeletal regulation by active forms of vitamin D"],"prefix":"10.1016","volume":"69","author":[{"given":"G.N.","family":"Hendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Hruska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5000091_bb0010","first-page":"200","article-title":"Structure\u2013function relationships in the vitamin D endocrine system","volume":"6","author":"Bouillon","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1038\/sj.ki.5000091_bb0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/me.2002-0363","article-title":"Vitamin D: more than a \u2018bone-a-fide\u2019 hormone","volume":"17","author":"Sutton","year":"2003","journal-title":"Molec Endocrinol"},{"issue":"Suppl","key":"10.1038\/sj.ki.5000091_bb0020","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1038\/sj.ki.5000091_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jsbmb.2004.03.016","article-title":"Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism","volume":"89\u201390","author":"Adams","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/sj.ki.5000091_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1010062929140","article-title":"Molecular nature of the vitamin D receptor and its role in regulation of gene expression","volume":"2","author":"Jurutka","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1038\/sj.ki.5000091_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1283","article-title":"Steroid hormone rapid actions, membrane receptors and a conformational ensemble model","volume":"3","author":"Norman","year":"2004","journal-title":"Nat Rev Drug Dis"},{"key":"10.1038\/sj.ki.5000091_bb0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.mnh.0000172721.44875.24","article-title":"Does calcitriol have actions independent from the vitamin D receptor in maintaining skeletal and mineral homeostasis?","volume":"14","author":"Hendy","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/sj.ki.5000091_bb0045","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted abalation of the 25-hydroxyvitamin D-1\u03b1-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5000091_bb0050","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","article-title":"Targeted inactivation of the 25-hydroxyvitamin D3-1\u03b1-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0055","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5000091_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/sj.ki.5000091_bb0065","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/mend.16.7.0866","article-title":"Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D","volume":"16","author":"Erben","year":"2002","journal-title":"Molec Endocrinol"},{"key":"10.1038\/sj.ki.5000091_bb0070","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197310182891601","article-title":"Pathogenesis of hereditary vitamin D-dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1\u03b1,25-dihroxyvitamin D","volume":"289","author":"Fraser","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000091_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.1981.tb00626.x","article-title":"Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25-dihydroxyvitaminD","volume":"14","author":"Beer","year":"1981","journal-title":"Clin Endocrinol"},{"key":"10.1038\/sj.ki.5000091_bb0080","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","article-title":"Inactivation of the 25-hydroxyvitamin D-1\u03b1-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis","volume":"279","author":"Panda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000091_bb0085","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/endo.139.10.6262","article-title":"Normalization by dietary means prevents hyperparathyroidism, rickets and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0090","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","article-title":"Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses","volume":"140","author":"Amling","year":"1999","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S8756-3282(03)00023-1","article-title":"Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1\u03b1-hydroxylase (CYP27B1)","volume":"32","author":"Dardenne","year":"2001","journal-title":"Bone"},{"key":"10.1038\/sj.ki.5000091_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jsbmb.2004.03.058","article-title":"Effects of calcium and of the vitamin D system on skeletal and calcium homeostasis: lessons from genetic models","volume":"89\u201390","author":"Goltzman","year":"2004","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1038\/sj.ki.5000091_bb0105","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/ddi160","article-title":"Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development","volume":"14","author":"Xue","year":"2005","journal-title":"Hum Molec Genet"},{"key":"10.1038\/sj.ki.5000091_bb0110","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1096\/fj.02-0225com","article-title":"Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice","volume":"16","author":"Hoenderop","year":"2002","journal-title":"FASEB J"},{"key":"10.1038\/sj.ki.5000091_bb0115","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1210\/endo.142.12.8544","article-title":"Aberrant growth plate development in VDR\/RXR\u03b3 double null mutant mice","volume":"142","author":"Yagishita","year":"2001","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/endo.140.2.6673","article-title":"Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice","volume":"140","author":"Takeda","year":"1999","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0125","first-page":"199","article-title":"Vitamin D control of osteoblast function and bone extracellular matrix mineralization","volume":"11","author":"van Leeuwen","year":"2001","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1038\/sj.ki.5000091_bb0130","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/1381612043383818","article-title":"Osteoblast differentiation and control by vitamin D and vitamin D metabolites","volume":"10","author":"van Driel","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1038\/sj.ki.5000091_bb0135","series-title":"Endocrine Society Meeting","article-title":"The anabolic effects of 1,25(OH)2vitamin D3 revealed by combining with alendronate","author":"Reszka","year":"2005"},{"issue":"Suppl1","key":"10.1038\/sj.ki.5000091_bb0140","first-page":"S51","article-title":"PTH and 1,25-dihydroxyvitamin D3 each independently exert skeletal anabolic effects and improve mineral ion homeostasis in mice which are homozygous for both the 1\u03b1-hydroxylase and PTH null alleles","volume":"20","author":"Xue","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5000091_bb0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-67-5-929","article-title":"Low dose calcitriol versus placebo in patients with predialysis chronic renal failure","volume":"67","author":"Nordal","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5000091_bb0150","first-page":"375","article-title":"Treatment of secondary hyperparathyroidism of pre dialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results","volume":"12","author":"Coen","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"10.1038\/sj.ki.5000091_bb0155","first-page":"1595","article-title":"Calcitriol and calcium carbonate therapy in early chronic renal failure","volume":"9","author":"Bianchi","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000091_bb0160","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","article-title":"Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital","volume":"3","author":"Mathias","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000420142","article-title":"Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy","volume":"90","author":"Goodman","year":"1991","journal-title":"Contrib Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J"},{"key":"10.1038\/sj.ki.5000091_bb0175","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000091_bb0180","series-title":"Vitamin D: Molecular, Cellular and Clinical Endocrinology","first-page":"83","article-title":"Bioavailability of calcitriol after oral, intravenous and intraperitoneal doses in dialysis patients","author":"Salusky","year":"1988"},{"key":"10.1038\/sj.ki.5000091_bb0185","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.V73488","article-title":"Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients","volume":"7","author":"Levine","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0195","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000091_bb0205","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0210","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","article-title":"Adynamic renal osteodystrophy: Is there a problem?","volume":"12","author":"Salusky","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0220","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0225","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0230","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric pateints with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0235","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0245","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000091_bb0250","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal diseases: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000091_bb0255","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5000091_bb0260","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1523-1755.2003.00932.x","article-title":"Aortic pulse wave velocity index and mortality in end-stage renal disease","volume":"63","author":"Blacher","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000091_bb0270","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.96.5.1477","article-title":"Ethnic origin and serum levels of Ia25-dihydroxyvitamin D sub3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography","volume":"96","author":"Doherty","year":"1997","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000091_bb0275","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","article-title":"Active serum vitamin D levels are inversely correlated with coronary calcification","volume":"96","author":"Watson","year":"1997","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000091_bb0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.ATV.20.2.317","article-title":"Warfarin-induced artery calcification is accelerated by growth and vitamin D","volume":"20","author":"Price","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.ki.5000091_bb0285","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by Warfarin and by Vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.ki.5000091_bb0290","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI117205","article-title":"TGF-\u03b21 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify","volume":"93","author":"Watson","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000091_bb0295","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1,25-dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide","volume":"98","author":"Jono","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000091_bb0300","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion","volume":"94","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000091_bb0305","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/endo.133.3.8396012","article-title":"The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine","volume":"133","author":"Brown","year":"1993","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000091_bb0310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0315","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","article-title":"22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure","volume":"55","author":"Monier-Faugere","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000091_bb0320","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2 suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0325","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol","volume":"38","author":"Sprague","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000091_bb0330","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000091_bb0335","first-page":"735A","article-title":"Paricalcitol improves mineralization and bone volume in a CKD model of the adynamic bone disorder (ABD) (abstract)","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000091_bb0340","first-page":"32","article-title":"Effects of paricalcitol therapy in the adynamic bone disorder (abstract)","volume":"16","author":"Mathew","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381551483X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381551483X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T09:27:19Z","timestamp":1626859639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381551483X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S008525381551483X"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000091","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}